Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rami Nabil Al‐Chaer"'
Autor:
Hans Christian Wulf, Rami Nabil Al-Chaer, Martin Glud, Peter Alshede Philipsen, Catharina Margrethe Lerche
Publikováno v:
Pharmaceuticals, Vol 14, Iss 5, p 433 (2021)
The high incidence of sunlight-induced human skin cancers reveals a need for more effective photosensitizing agents. In this study, we compared the efficacy of prophylactic photodynamic therapy (PDT) when methylene blue (MB), riboflavin (RF), or meth
Externí odkaz:
https://doaj.org/article/a5527e304fde4689a6ce788703aa92a1
Publikováno v:
Experimental Dermatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f1434cff226818b3ba46de32ea617fa
https://doi.org/10.1111/exd.14830
https://doi.org/10.1111/exd.14830
Autor:
Hans Christian Wulf, Rami Nabil Al-Chaer, Peter A. Philipsen, Catharina M. Lerche, Martin Glud
Publikováno v:
Photochemical & Photobiological Sciences. 20:1299-1307
PUVA is a treatment that combines oral methoxypsoralen (8-MOP) with ultraviolet radiation A (UVA). It is used for severe psoriasis and the early stages of T-cell lymphoma. X-rays are an effective treatment for skin cancers. Both treatments are in hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45d426e540b849c0db2be6881ce7c53
https://doi.org/10.1007/s43630-021-00105-y
https://doi.org/10.1007/s43630-021-00105-y
Publikováno v:
Lerche, C M, Al-Chaer, R N & Wulf, H C 2023, ' Does systemic hydrochlorothiazide increase the risk of developing ultraviolet radiation-induced skin tumours in hairless mice? ', Experimental Dermatology, vol. 32, no. 4, pp. 341-347 . https://doi.org/10.1111/exd.14703
Hydrochlorothiazide (HCTZ) is a frequently prescribed diuretic that exhibits photosensitizing properties. It is used to treat hypertension and edema. Dermato-epidemiological studies in various populations have linked HCTZ treatment with increased ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e7cf43d6d2172835670cfa10dfad29
https://pubmed.ncbi.nlm.nih.gov/36333872
https://pubmed.ncbi.nlm.nih.gov/36333872
Autor:
Catharina M, Lerche, Rami Nabil, Al-Chaer, Martin, Glud, Peter Alshede, Philipsen, Hans Christian, Wulf
Publikováno v:
Photochemicalphotobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology. 20(10)
PUVA is a treatment that combines oral methoxypsoralen (8-MOP) with ultraviolet radiation A (UVA). It is used for severe psoriasis and the early stages of T-cell lymphoma. X-rays are an effective treatment for skin cancers. Both treatments are in hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5f0e96cc7c16fb3ca2217d146acbc8c
https://pubmed.ncbi.nlm.nih.gov/34559384
https://pubmed.ncbi.nlm.nih.gov/34559384
Autor:
Rami Nabil Al-Chaer, Martin Glud, Hans Christian Wulf, Catharina M. Lerche, Peter A. Philipsen
Publikováno v:
Pharmaceuticals
Volume 14
Issue 5
Pharmaceuticals, Vol 14, Iss 433, p 433 (2021)
Wulf, H C, Al-Chaer, R N, Glud, M, Philipsen, P A & Lerche, C M 2021, ' A Skin Cancer Prophylaxis Study in Hairless Mice Using Methylene Blue, Riboflavin, and Methyl Aminolevulinate as Photosensitizing Agents in Photodynamic Therapy ', Pharmaceuticals, vol. 14, no. 5, 433 . https://doi.org/10.3390/ph14050433
Volume 14
Issue 5
Pharmaceuticals, Vol 14, Iss 433, p 433 (2021)
Wulf, H C, Al-Chaer, R N, Glud, M, Philipsen, P A & Lerche, C M 2021, ' A Skin Cancer Prophylaxis Study in Hairless Mice Using Methylene Blue, Riboflavin, and Methyl Aminolevulinate as Photosensitizing Agents in Photodynamic Therapy ', Pharmaceuticals, vol. 14, no. 5, 433 . https://doi.org/10.3390/ph14050433
The high incidence of sunlight-induced human skin cancers reveals a need for more effective photosensitizing agents. In this study, we compared the efficacy of prophylactic photodynamic therapy (PDT) when methylene blue (MB), riboflavin (RF), or meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e5f569a14e20ad60155b921f895a72